{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:52:37Z","timestamp":1776477157047,"version":"3.51.2"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.survophthal.2008.08.011","type":"journal-article","created":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T04:59:27Z","timestamp":1227934767000},"page":"S85-S92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"S","title":["A Review of Additivity to Prostaglandin Analogs: Fixed and Unfixed Combinations"],"prefix":"10.1016","volume":"53","author":[{"given":"Rania","family":"Tabet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios G.P.","family":"Konstas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2008.08.011_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators","volume":"130","author":"___: The Advanced Glaucoma Intervention Study (AGIS)","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2005.02.043","article-title":"The safety and efficacy of travoprost 0.004%\/timolol 0.5% fixed combination ophthalmic solution","volume":"140","author":"Barnebey","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib3","first-page":"39","article-title":"[The ocular hypotensive effect of the combination of latanoprost with dorzolamide]","volume":"46","author":"Chiselita","year":"1999","journal-title":"Oftalmologia"},{"key":"10.1016\/j.survophthal.2008.08.011_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/112067210601600308","article-title":"A comparison of morning and evening instillation of a combination travoprost 0.004%\/timolol 0.5% ophthalmic solution","volume":"16","author":"Denis","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004170050124","article-title":"Almeg\u00e5rd B: Comparison of two fixed\u00a0combinations of latanoprost and timolol in open-angle glaucoma","volume":"236","author":"Diestelhorst","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ophtha.2005.06.027","article-title":"A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components","volume":"113","author":"Diestelhorst","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjo.2003.018234","article-title":"A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension","volume":"88","author":"Diestelhorst","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02849907","article-title":"Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol","volume":"24","author":"Dunker","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.survophthal.2008.08.011_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0021-5155(03)00106-0","article-title":"A short-term study of the additive effect of latanoprost 0.005% and brimonidine 0.2%","volume":"47","author":"Erdo\u01e7an","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/14656566.5.4.909","article-title":"An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension","volume":"5","author":"Feldman","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.survophthal.2008.08.011_bib11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ophtha.2007.03.012","article-title":"Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%","volume":"114","author":"Feldman","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1185\/030079906X120904","article-title":"Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension","volume":"22","author":"Franks","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.survophthal.2008.08.011_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clinthera.2006.03.001","article-title":"A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%\/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Franks","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.survophthal.2008.08.011_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bjo.2003.029330","article-title":"A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe","volume":"88","author":"Garc\u00eda-S\u00e1nchez","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2008.08.011_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0039-6257(02)00295-3","article-title":"The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications","volume":"47","author":"Higginbotham","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archopht.120.7.915","article-title":"Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial","volume":"120","author":"Higginbotham","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/112067210601600606","article-title":"The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma","volume":"16","author":"Holl\u00f3","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/112067210701700108","article-title":"A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%\/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension","volume":"17","author":"Hommer","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002512-200623070-00005","article-title":"Travoprost\/timolol","volume":"23","author":"Hoy","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.survophthal.2008.08.011_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003495-200059030-00003","article-title":"van Beek LM: Pharmacological therapy for glaucoma: a review","volume":"59","author":"Hoyng","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2008.08.011_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.ijg.0000176935.08392.14","volume":"14","author":"Hughes","year":"2005","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2008.08.011_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1006176713983","article-title":"G\u00fcler C: Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure","volume":"22","author":"Kimal Arici","year":"1998","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/jop.2004.20.375","article-title":"Intraocular pressure and safety in glaucoma patients switching to latanoprost\/timolol maleate fixed combination from mono- and adjunctive therapies","volume":"20","author":"Konstas","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2008.08.011_bib26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archopht.123.7.898","article-title":"Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy","volume":"123","author":"Konstas","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ophtha.2004.11.032","article-title":"24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects","volume":"112","author":"Konstas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib28","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.eye.6701446","article-title":"Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%\/timolol maleate 0.5% and dorzolamide 2%\/timolol maleate 0.5%","volume":"18","author":"Konstas","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2008.08.011_bib29","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archopht.124.11.1553","article-title":"24-Hour control with a latanoprost-timolol fixed combination vs timolol alone","volume":"124","author":"Konstas","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9394(99)00073-2","article-title":"Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma","volume":"128","author":"Konstas","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/eye.2000.197","article-title":"Compliance and viewpoint of glaucoma patients in Greece","volume":"14","author":"Konstas","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2008.08.011_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0002-9394(02)01460-5","article-title":"A comparison of once-daily morning vs evening dosing of concomitant latanoprost\/timolol","volume":"133","author":"Konstas","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib33","doi-asserted-by":"crossref","unstructured":"Konstas AGP, Tsironi S, Vakalis AN, et al: Intraocular pressure control over 24 hours using travopost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma. Acta Ophthalmol Scand: (In press 2008)","DOI":"10.1111\/j.1755-3768.2007.01145.x"},{"key":"10.1016\/j.survophthal.2008.08.011_bib34","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","article-title":"Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure","volume":"138","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ophtha.2005.11.011","article-title":"Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication","volume":"113","author":"Magacho","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","article-title":"Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials","volume":"331","author":"Maier","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2008.08.011_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14656566.9.1.137","article-title":"Efficacy and safety of bimatoprost\/timolol fixed combination in the treatment of glaucoma or ocular hypertension","volume":"9","author":"Martinez","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.survophthal.2008.08.011_bib39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1185\/030079907X182149","article-title":"A comparison of the safety and intraocular pressure lowering of bimatoprost\/timolol fixed combination versus latanoprost\/timolol fixed combination in patients with open-angle glaucoma","volume":"23","author":"Martinez","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.survophthal.2008.08.011_bib40","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1185\/030079904125004529","article-title":"Concomitant administration of travoprost and brinzolamide versus fixed latanoprost\/timolol combined therapy: three-month comparison of efficacy and safety","volume":"20","author":"Martinez-de-la-Casa","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.survophthal.2008.08.011_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.ijg.0000212240.11219.49","article-title":"Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial","volume":"15","author":"Maruyama","year":"2006","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2008.08.011_bib42","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2105\/AJPH.86.12.1805","article-title":"Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race","volume":"86","author":"Monane","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1016\/j.survophthal.2008.08.011_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02850116","article-title":"Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension","volume":"20","author":"Netland","year":"2003","journal-title":"Adv Ther"},{"key":"10.1016\/j.survophthal.2008.08.011_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1358\/dot.2007.43.2.1032058","article-title":"Travoprost 0.004%\/timolol 0.5% fixed combination","volume":"43","author":"Noecker","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.survophthal.2008.08.011_bib45","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0002-9394(02)01418-6","article-title":"Additive intraocular pressure lowering effect of various medications with latanoprost","volume":"133","author":"O'Connor","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.clinthera.2004.10.009","article-title":"Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension","volume":"26","author":"Olander","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.survophthal.2008.08.011_bib48","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.survophthal.2008.08.011_bib49","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00417-002-0553-0","article-title":"A comparison of the fixed combination of latanoprost and timolol with its individual components","volume":"240","author":"Pfeiffer","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinthera.2006.04.007","article-title":"A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Reis","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.survophthal.2008.08.011_bib51","first-page":"1","article-title":"A study of the safety and effi cacy of travoprost 0.004%\/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension","volume":"2","author":"Rhee","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib53","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2005.02.058","article-title":"Efficacy and safety of a fixed combination of travoprost 0.004%\/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension","volume":"140","author":"Schuman","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ophtha.2003.05.019","article-title":"Efficacy and safety of the fixed combinations latanoprost\/timolol versus dorzolamide\/timolol in patients with elevated intraocular pressure","volume":"111","author":"Shin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2008.08.011_bib55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1185\/030079905X38222","article-title":"Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study","volume":"21","author":"Shoji","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.survophthal.2008.08.011_bib56","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0002-9394(99)00237-8","article-title":"Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost","volume":"128","author":"Stewart","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1034\/j.1600-0420.2003.00065.x","article-title":"Efficacy and safety of timolol maleate\/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily","volume":"81","author":"Stewart","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2008.08.011_bib58","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/sj.eye.6701375","article-title":"Efficacy and safety of the latanoprost\/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy","volume":"18","author":"Stewart","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2008.08.011_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000097903","article-title":"Oks\u00fcz H: Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost","volume":"39","author":"Tamer","year":"2007","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2008.08.011_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/112067210701700206","article-title":"A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%\/timolol 0.5% to once-daily latanoprost 0.005%\/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension","volume":"17","author":"Topouzis","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9394(98)00155-X","article-title":"Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow","volume":"126","author":"Vanlandigham","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.08.011_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/14728214.12.2.313","article-title":"Fixed-combination and emerging glaucoma therapies","volume":"12","author":"Woodward","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.survophthal.2008.08.011_bib63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF02850256","article-title":"Comparison of brimonidine\/latanoprost and timolol\/dorzolamide: two randomized, double-masked, parallel clinical trials","volume":"20","author":"Zabriskie","year":"2003","journal-title":"Adv Ther"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625708001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625708001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:34:29Z","timestamp":1758540869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625708001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0039625708001367"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2008.08.011","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Additivity to Prostaglandin Analogs: Fixed and Unfixed Combinations","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2008.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}